Overview and Scope
A DNA and gene chip is a microchip that contains microscopic DNA probes attached to a solid surface that can identify DNA from test samples and make up half of the DNA double helix. If the test sample of DNA has the mutation, then the DNA will not bind properly to the sequence on the chip. The DNA and gene chip is used to measure the expression levels of genes or to ascertain whether a particular person’s DNA has mutations in genes which are variations in DNA which can cause ailments.
Sizing and Forecast
The dna and gene chip market size has grown rapidly in recent years. It will grow from $7.38 billion in 2023 to $8.4 billion in 2024 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to genomic research advancements, rise of personalized medicine, human genome project milestones, drug discovery and development, disease biomarker identification..
The dna and gene chip market size is expected to see rapid growth in the next few years. It will grow to $13.7 billion in 2028 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period can be attributed to advancements in precision medicine, expansion of biomarker discovery, growth of personalized therapeutics, application in cancer research, increasing research funding.. Major trends in the forecast period include technological advancements, product innovations, regulatory framework and compliance, focus on rare diseases, continuous reduction in costs..
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/dna-and-gene-chip-global-market-report
Segmentation & Regional Insights
The dna and gene chip market covered in this report is segmented –
1) By Type: Oligonucleotide DNA (o-DNA), Complementary DNA (c-DNA), Other Types
2) By Application: Cancer Diagnostics, Gene Expression, Proteomics, Genomics, Drug Discovery, Agrigenomics, Other Applications
3) By End User: Academic And Government Research Institutes, Biotechnology And Pharmaceutical Companies, Hospitals And Diagnostics Centers, Other End Users
Top Major Players:
PerkinElmer Inc.I
llumina Inc.
Thermo Fisher Scientific Inc.
Macrogen Inc
Agilent Technologies Inc.
North America was the largest region in the DNA and gene chip market share in 2023.
North America was the largest region in the DNA and gene chip market share in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dna and gene chip market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8205&type=smp
Major Driver Impacting Market Growth
The rising demand for early cancer detection is significantly contributing to the growth of the DNA and gene market. Cancer is a broad class of conditions that can develop in practically any organ or tissue of the body when aberrant cells multiply uncontrollably, cross normal cell boundaries to invade nearby organs, and spread to other regions of the body. DNA and gene chips are used to measure gene expression patterns, determine the genetic and epigenetic landscape, and measure genomic regulatory elements bound by cancer transcription factors in cancerous cells. For instance, in 2022, according to the American Cancer Society, a US-based community-based, voluntary health organization, it is projected that there will be approximately 1.9 million newly diagnosed cancer cases and 609,360 deaths from cancer in the United States. Therefore, rising demand for early cancer detection is driving the growth of the DNA and gene chip market.
Key Industry Players
Major companies operating in the dna and gene chip market report are PerkinElmer Inc., Illumina Inc., Thermo Fisher Scientific Inc., Macrogen Inc., Agilent Technologies Inc., Greiner Bio-One International GmbH, CapitalBio Corporation, Microarrays Inc., bioMérieux SA, Applied Microarrays Inc., Biometrix Technology Inc., Oxford Gene Technology IP Limited, Affymetrix Inc., Bioneer Corporation, Eurofins MWG Operon LLC, F. Hoffmann-La Roche Ltd, QIAGEN N.V., Bio-Rad Laboratories Inc., Arrayit Corporation, BioChain Institute Inc., Cepheid, Clontech Laboratories Inc., Eppendorf AG, Fluidigm Corporation, GE Healthcare, Genisphere LLC, Gyros Protein Technologies AB, Hitachi High-Technologies Corporation, LC Sciences, Luminex Corporation
The dna and gene chip market report table of contents includes:
1. Executive Summary
2. DNA And Gene Chip Market Characteristics
3. DNA And Gene Chip Market Trends And Strategies
4. DNA And Gene Chip Market – Macro Economic Scenario
5. Global DNA And Gene Chip Market Size and Growth
…
31. Global DNA And Gene Chip Market Competitive Benchmarking
32. Global DNA And Gene Chip Market Competitive Dashboard
33. Key Mergers And Acquisitions In The DNA And Gene Chip Market
34.DNA And Gene Chip Market Future Outlook and Potential Analysis
35. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
